The Digest’s 2022 Multi-Slide ABLC Guide to Arzeda

Arzeda’s combination of computational protein design and state-of-the-art high-throughput screening is a radical change over what’s possible with traditional protein engineering. Our proprietary technology has been peer-reviewed in Science and Nature, and is based on solid and vetted models of protein biophysics and metabolic biochemistry coupled with large-scale computing. CEO Alexandre Zanghellini presented these slides at ABLC Next 2022.